Recurrent Pregnancy Loss (RPL) in Lucknow: What Every Couple Needs to Know

Recurrent pregnancy loss is classified by most international reproductive medicine bodies — including the European Society of Human Reproduction and Embryology (ESHRE) — as two or more failed clinical pregnancies, confirmed by ultrasound or histopathology. In India, many specialists still follow the older WHO threshold of three or more losses, which can delay investigation by months or even years for Lucknow couples.

RPL is distinct from infertility: women with RPL can typically conceive but cannot sustain the pregnancy to viability. Losses may be biochemical (detected only by a positive hCG that then falls), clinical early miscarriages (before 8 weeks), or late first-trimester losses (8–12 weeks). Each pattern points to a different cluster of causes and demands a different diagnostic approach.

At HomeIVF, the Medical Board follows the ESHRE 2023 guideline: investigation begins after two losses, not three, because early identification dramatically improves outcomes. Couples in Lucknow — whether in the fast-growing residential corridors of Aliganj or the older neighbourhoods of Hazratganj — are encouraged to seek evaluation without waiting for a third loss to occur.

Understanding why RPL happens is the first step toward preventing it. The causes broadly fall into five categories, and in many couples more than one factor is present simultaneously.

**Chromosomal / Genetic Factors:** Embryonic aneuploidy (abnormal chromosome number) is the single most common cause, responsible for 50–60% of sporadic first-trimester losses. Parental balanced translocations, though rarer (found in 3–5% of RPL couples), cause repeated embryo chromosomal errors and can be identified through parental karyotyping.

**Uterine Structural Abnormalities:** Septate uterus, submucous fibroids, intrauterine adhesions (Asherman's syndrome), and bicornuate uterus collectively account for 10–15% of RPL. A 3D transvaginal ultrasound or hysteroscopy can detect these with high accuracy.

**Thrombophilia and Clotting Disorders:** Antiphospholipid Syndrome (APS) — the most clinically significant acquired thrombophilia — is found in 5–15% of RPL patients and is highly treatable with low-dose aspirin and low-molecular-weight heparin.

**Hormonal and Metabolic Causes:** Uncontrolled thyroid disorders (both hypothyroidism and hyperthyroidism), poorly managed PCOS, hyperprolactinaemia, and undiagnosed diabetes contribute meaningfully to implantation failure and early loss.

**Unexplained RPL:** Even after full investigation, 30–40% of cases remain unexplained — but crucially, these couples still have a 60–70% chance of a successful next pregnancy with supportive care and close monitoring.

Many couples in Lucknow delay seeking specialised RPL evaluation because each individual loss is often managed by a general gynaecologist who reassures them that 'one miscarriage is common.' While this is statistically true, couples who have experienced two or more losses deserve a systematic investigation — not reassurance alone.

Seek a dedicated RPL consultation if you experience: two or more pregnancy losses at any gestation; one or more losses after 10 weeks (late first-trimester losses are less likely to be random chromosomal events and more likely to reflect maternal factors); a history of preterm birth combined with early losses; or any pregnancy loss in a woman over 35, where the window for investigation and treatment is narrower.

Additionally, women who have been diagnosed with PCOS, thyroid disease, or an autoimmune condition should flag their history proactively, even after a first loss. Couples in high-traffic areas like Gomti Nagar and Indira Nagar who cannot take repeated half-days off work for clinic visits will find HomeIVF's teleconsultation and home-sample-collection model especially valuable for initiating this workup without disrupting daily routines.

A structured RPL workup typically takes 3–6 weeks to complete and involves both partners. The HomeIVF Medical Board recommends the following evidence-based panel for patients in Lucknow.

**Genetic Testing:** Parental karyotyping (peripheral blood chromosomal analysis) for both partners. If recurrent embryo loss is suspected to be chromosomal, preimplantation genetic testing for aneuploidy (PGT-A) during an IVF cycle can screen embryos before transfer.

**Uterine Assessment:** Transvaginal ultrasound (TVS) with 3D capability is the first-line investigation. Saline infusion sonography (SIS) or diagnostic hysteroscopy is added when structural pathology is suspected.

**Thrombophilia Screen:** Anticardiolipin antibodies (IgG and IgM), anti-β2 glycoprotein-I antibodies, lupus anticoagulant, Factor V Leiden mutation, prothrombin gene mutation, and protein C/S levels.

**Hormonal Profile:** TSH (targeting < 2.5 mIU/L in women trying to conceive), fasting glucose and insulin, prolactin, AMH, and a Day 2–3 FSH/LH/estradiol panel.

**Immunological Tests:** Natural killer (NK) cell assay and endometrial receptivity analysis (ERA) may be added in unexplained RPL where implantation failure is suspected.

HomeIVF coordinates home blood collection across Lucknow, delivering samples to accredited NABL laboratories, so couples do not need to visit multiple diagnostic centres scattered across the city.

Treatment for RPL is never one-size-fits-all — it depends entirely on the root cause identified during workup. The HomeIVF Medical Board designs individualised protocols for each couple.

**For Chromosomal Causes:** If a parental translocation is identified, IVF with PGT-A is recommended. PGT-A screens each embryo for the correct number of chromosomes before uterine transfer, significantly reducing miscarriage risk in subsequent cycles.

**For Uterine Abnormalities:** A uterine septum can be resected hysteroscopically as a day-care procedure. Submucous fibroids and intrauterine adhesions can similarly be treated before attempting conception again.

**For Antiphospholipid Syndrome:** The combination of low-dose aspirin (75–100 mg/day) commenced before conception and low-molecular-weight heparin (LMWH) from a positive pregnancy test is the standard of care, improving live birth rates by 50–54% in APS patients.

**For Hormonal Causes:** Optimising thyroid function (TSH < 2.5 mIU/L), managing PCOS with metformin or inositol, and normalising prolactin with cabergoline each contribute to improved pregnancy outcomes.

**For Unexplained RPL:** Progesterone supplementation in the luteal phase and early pregnancy, close ultrasound surveillance ('tender loving care' protocols), and psychological support are evidence-backed interventions. HomeIVF packages starting from ₹1.5 lakh include coordinated monitoring for exactly these couples.

One of the most underappreciated aspects of RPL management is the need for intensive, consistent monitoring in early pregnancy — fortnightly or even weekly blood tests and ultrasounds in the first trimester. For working couples in Lucknow, travelling to a fertility clinic in Hazratganj or across town to Gomti Nagar every seven days is a logistical burden that often results in missed tests and delayed dose adjustments.

HomeIVF's home-monitoring model addresses this directly. A trained HomeIVF phlebotomist visits the patient's home for serial hCG and progesterone draws. Results are reviewed by the HomeIVF Medical Board within 24 hours, and medication adjustments — such as increasing progesterone supplementation or changing LMWH dosing — are communicated via a dedicated app notification and a follow-up telecall.

This model also captures the early biochemical signals of a threatened pregnancy before symptoms appear, allowing proactive intervention rather than reactive management. For RPL patients, who carry significant anxiety into every new pregnancy, knowing that a specialist eye is watching their numbers daily provides a level of psychological reassurance that cannot be replicated by a monthly clinic appointment. Families in Aliganj and Indira Nagar have particularly benefited from avoiding rush-hour commutes during medically sensitive early-pregnancy weeks.

Despite being Uttar Pradesh's capital and a major medical hub, Lucknow still presents structural barriers to comprehensive RPL care that couples rarely discuss openly.

**Fragmentation of care:** Most couples see a general gynaecologist for the miscarriage itself, a separate haematologist for clotting tests, and an endocrinologist for thyroid management — with no single coordinator connecting the findings. HomeIVF's care-team model assigns a dedicated case manager who integrates reports from all specialists into one treatment plan.

**Social stigma and silence:** In many Lucknow families — particularly in joint family setups common in neighbourhoods like Hazratganj and older parts of Aliganj — repeated pregnancy loss carries unspoken shame. Women often delay seeking help to avoid family pressure. HomeIVF's teleconsultation model ensures complete privacy: no waiting rooms, no chance encounters at a well-known local clinic.

**Access to advanced diagnostics:** PGT-A, ERA, and NK cell testing are not available in every Lucknow laboratory. HomeIVF partners with accredited reference labs and coordinates sample logistics so that Lucknow patients can access these tests without travelling to Delhi or Mumbai.

**Language and communication:** HomeIVF care coordinators are available in Hindi, ensuring that medical findings are explained in a language patients are fully comfortable with — a small but meaningful detail that significantly improves adherence to treatment.

Couples dealing with RPL often arrive at their first consultation asking the most important question: 'Will we ever have a healthy baby?' The honest, evidence-based answer — for most couples — is yes, with appropriate investigation and treatment.

For couples where an identifiable cause is found and treated, cumulative live birth rates in subsequent pregnancies range from 60–80%, depending on the cause and the couple's age. Even in unexplained RPL — the most emotionally frustrating category — around 60–70% of couples who enter a structured supportive-care protocol go on to achieve a live birth.

Age remains the most significant independent variable: women under 35 with unexplained RPL have live birth rates closer to 70–75%; women over 40 are more likely to have age-related embryo aneuploidy as the primary driver, and IVF with PGT-A offers the most reliable path forward in that group.

The HomeIVF Medical Board tracks outcomes for every Lucknow patient in its care, enabling continuous protocol refinement. Couples who have completed their workup and treatment through HomeIVF report not just improved clinical outcomes but also a measurable reduction in pregnancy-related anxiety — a dimension of care that matters enormously when every positive test brings both hope and fear.